"Huntington Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
Descriptor ID |
D006816
|
MeSH Number(s) |
C10.228.140.079.545 C10.228.140.380.278 C10.228.662.262.249.750 C10.574.500.497 C16.320.400.430 F03.615.250.400 F03.615.400.390
|
Concept/Terms |
Huntington Disease- Huntington Disease
- Huntington Chorea
- Chorea, Huntington
- Huntington's Disease
- Chronic Progressive Hereditary Chorea (Huntington)
- Huntington Chronic Progressive Hereditary Chorea
- Progressive Chorea, Chronic Hereditary (Huntington)
- Progressive Chorea, Hereditary, Chronic (Huntington)
- Huntington's Chorea
- Chorea, Huntington's
- Chorea, Chronic Progressive Hereditary (Huntington)
Juvenile Huntington Disease- Juvenile Huntington Disease
- Juvenile-Onset Huntington Disease
- Juvenile Onset Huntington Disease
- Huntington Disease, Juvenile-Onset
- Huntington Disease, Juvenile Onset
- Huntington Disease, Juvenile
|
Below are MeSH descriptors whose meaning is more general than "Huntington Disease".
Below are MeSH descriptors whose meaning is more specific than "Huntington Disease".
This graph shows the total number of publications written about "Huntington Disease" by people in this website by year, and whether "Huntington Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 0 | 4 |
1996 | 2 | 0 | 2 |
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
1999 | 1 | 1 | 2 |
2000 | 2 | 2 | 4 |
2001 | 0 | 2 | 2 |
2002 | 2 | 1 | 3 |
2003 | 2 | 2 | 4 |
2004 | 3 | 1 | 4 |
2005 | 1 | 0 | 1 |
2006 | 2 | 1 | 3 |
2007 | 2 | 3 | 5 |
2008 | 5 | 1 | 6 |
2009 | 1 | 0 | 1 |
2010 | 5 | 1 | 6 |
2011 | 3 | 0 | 3 |
2012 | 9 | 2 | 11 |
2013 | 4 | 1 | 5 |
2014 | 3 | 1 | 4 |
2015 | 2 | 0 | 2 |
2016 | 5 | 1 | 6 |
2017 | 4 | 0 | 4 |
2018 | 3 | 1 | 4 |
2019 | 1 | 2 | 3 |
2020 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2022 | 3 | 0 | 3 |
2023 | 2 | 0 | 2 |
2024 | 2 | 0 | 2 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Huntington Disease" by people in Profiles.
-
Regulation of Mutant Huntingtin Mitochondrial Toxicity by Phosphomimetic Mutations within Its N-Terminal Region. J Neurosci. 2025 Feb 19; 45(8).
-
Systemic Symptoms in Huntington's Disease: A Comprehensive Review. Mov Disord Clin Pract. 2024 May; 11(5):453-464.
-
Concern about Tominersen in Patients with Huntington's Disease. Reply. N Engl J Med. 2024 Mar 14; 390(11):1059.
-
Tominersen in Adults with Manifest Huntington's Disease. N Engl J Med. 2023 Dec 07; 389(23):2203-2205.
-
An altered extracellular matrix-integrin interface contributes to Huntington's disease-associated CNS dysfunction in glial and vascular cells. Hum Mol Genet. 2023 04 20; 32(9):1483-1496.
-
Suppression of toxicity of the mutant huntingtin protein by its interacting compound, desonide. Proc Natl Acad Sci U S A. 2022 03 08; 119(10):e2114303119.
-
Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease. Cell Syst. 2022 04 20; 13(4):304-320.e5.
-
The developmental roots of neurodegeneration. Neuron. 2022 01 05; 110(1):1-3.
-
Inhibition of HIPK3 by AST487 Ameliorates Mutant HTT-Induced Neurotoxicity and Apoptosis via Enhanced Autophagy. Neurosci Bull. 2022 Jan; 38(1):99-103.
-
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis. Elife. 2021 04 19; 10.